A detailed history of Rothschild Investment LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 60 shares of SWTX stock, worth $2,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 10 500.0%
Holding current value
$2,246
Previous $377,000 409.81%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$32.04 - $42.76 $1,602 - $2,138
50 Added 500.0%
60 $1.92 Million
Q2 2024

Jul 30, 2024

BUY
$36.06 - $47.62 $360 - $476
10 New
10 $377,000
Q1 2024

Jul 31, 2024

SELL
$36.5 - $52.5 $182 - $262
-5 Reduced 50.0%
5 $246,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.